Paul U Cameron
Overview
Explore the profile of Paul U Cameron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
3412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pitman M, Meagher N, Price D, Rhodes A, Chang J, Scher B, et al.
J Virus Erad
. 2023 Sep;
9(3):100345.
PMID: 37753336
Introduction: Antiretroviral therapy for people living with HIV-1 must be taken lifelong due to the persistence of latent virus in long-lived and proliferating CD4 T cells. Vitamin D is a...
2.
Rasmussen T, Zerbato J, Rhodes A, Tumpach C, Dantanarayana A, McMahon J, et al.
Cell Rep Med
. 2022 Oct;
3(10):100766.
PMID: 36198308
Programmed cell death 1 (PD1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4) suppress CD4 T cell activation and may promote latent HIV infection. By performing leukapheresis (n = 21) and...
3.
Richardson Z, Deleage C, Tutuka C, Walkiewicz M, Del Rio-Estrada P, Pascoe R, et al.
J Immunol Methods
. 2021 Dec;
501:113198.
PMID: 34863818
The main barrier to a cure for HIV is the persistence of long-lived and proliferating latently infected CD4 T-cells despite antiretroviral therapy (ART). Latency is well characterized in multiple CD4...
4.
Chiu C, Chang J, Dantanarayana A, Solomon A, Evans V, Pascoe R, et al.
J Immunol
. 2021 Dec;
208(1):54-62.
PMID: 34853078
In people with HIV (PWH) on antiretroviral therapy (ART), immune dysfunction persists, including elevated expression of immune checkpoint (IC) proteins on total and HIV-specific T cells. Reversing immune exhaustion is...
5.
Bacchus-Souffan C, Fitch M, Symons J, Abdel-Mohsen M, Reeves D, Hoh R, et al.
PLoS Pathog
. 2021 Jan;
17(1):e1009214.
PMID: 33465157
The precise role of CD4 T cell turnover in maintaining HIV persistence during antiretroviral therapy (ART) has not yet been well characterized. In resting CD4 T cell subpopulations from 24...
6.
Hartley G, Edwards E, Bosco J, Ojaimi S, Stirling R, Cameron P, et al.
Clin Transl Immunology
. 2020 Oct;
9(10):e1199.
PMID: 33088507
Background: Annual influenza vaccination is recommended to all individuals over 6 months of age, including predominantly antibody deficiency (PAD) patients. Vaccination responses are typically evaluated by serology, and because PAD...
7.
van der Sluis R, Zerbato J, Rhodes J, Pascoe R, Solomon A, Kumar N, et al.
PLoS Pathog
. 2020 Feb;
16(2):e1008151.
PMID: 32109259
HIV latency is the major barrier to a cure for people living with HIV (PLWH) on antiretroviral therapy (ART) because the virus persists in long-lived non-proliferating and proliferating latently infected...
8.
van der Sluis R, Kumar N, Pascoe R, Zerbato J, Evans V, Dantanarayana A, et al.
J Immunol
. 2020 Jan;
204(5):1242-1254.
PMID: 31988180
In people living with HIV on antiretroviral therapy, HIV latency is the major barrier to a cure. HIV persists preferentially in CD4 T cells expressing multiple immune checkpoint (IC) molecules,...
9.
Kim Y, Cameron P, Lewin S, Anderson J
J Int AIDS Soc
. 2019 Dec;
22(12):e25425.
PMID: 31855322
Introduction: HIV latency can be established in vitro following direct infection of a resting CD4+ T cell (pre-activation latency) or infection of an activated CD4+ T cell which then returns...
10.
Roche M, Tumpach C, Symons J, Gartner M, Anderson J, Khoury G, et al.
J Virol
. 2019 Dec;
94(6).
PMID: 31852784
HIV can persist in people living with HIV (PLWH) on antiretroviral therapy (ART) in multiple CD4 T cell subsets, including naive cells, central memory (CM) cells, transitional (TM) cells, and...